Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

 

Fight for Sight (square)

Donation from the Tommy Salisbury Choroideremia Fund

(31 January 2017)

 

 

 

 

Microperimeter

An extremely generous donation of £57,230 has been received from Emma Salisbury and Dot Grindley, the Trustees of the Tommy Salisbury Choroideremia Fund at Fight for Sight, for the purchase of a scotopic microperimeter for use in our ongoing Phase 2 choroideremia gene therapy trial.

The scotopic microperimeter will permit the clinical evaluation of the effect of gene therapy on restoration of vision in low light conditions. Choroideremia patients who received our gene therapy treatment in our previous Phase 1 clinical trial reported being “able to see the stars again”. This scotopic microperimeter will provide us with an objective and quantitative measurement of restoration of night vision in choroideremia patients receiving gene therapy treatment in our Phase 2 clinical trial.

This data will be essential for eventual FDA approval of our choroideremia gene therapy as a licenced medicinal product.

 

 

 

 

Fight for Sight (square)National Eye Research Centre (small)Reception for benefactors

(8 November 2016)

 

 

 

 

Visit by FFS and NERC (8 November 2016)

Professor Robert MacLaren was pleased to welcome to Oxford some of the principal benefactors involved in the recent fundraising campaign for the ophthalmic operating microscope with an integrated optical coherence tomography (OCT). The guests included Mike Daw, the Chief Executive Officer of the National Eye Research Centre, Dr Dolores Conroy, Director of Research at Fight for Sight, and Emma Salisbury and Dot Grindley, Trustees of the Tommy Salisbury Choroideremia Fund at Fight for Sight. The guests were shown the OCT microscope by Professor Robert MacLaren and his assistant Dr Kanmin Xue, followed by a reception at Merton College.

 

 

 

JustGivingJustGiving crowdfunding campaign

(26 August 2016)

 

 

OCT Microscope Crowdfunding

On 29 December 2015 a JustGiving webpage was set up by the Clinical Ophthalmology Research Group with the assistance of Fight for Sight, a leading blindness charity. This crowdfunding campaign permitted members of the public to actively assist us to reach our fundraising target of £192,000 for the purchase of an ophthalmic operating microscope with an integrated optical coherence tomography (OCT) scanner.

The support from the members of the public was fantastic, with over £3,500 received in private donations in addition to funds pledged by a number of blindness charities (Fight for Sight, the National Eye Research Centre, the Tommy Salisbury Choroideremia Fund, the Saturday Hospital Fund and the Choroideremia Research Foundation USA). The Clinical Ophthalmology Research Group is therefore pleased to announce that our fundraising target of £192,000 was reached and the OCT microscope was delivered to the Oxford Eye Hospital on 26 August 2016 - in time for the treatment of our first patient enrolled in our Phase 2 choroideremia gene therapy trial.

 

 

 

ZIZOZDonation from Zien Zonder Zorgen (ZIZOZ)

(14 April 2016)

 

 

 

 

 

 

On 14 April 2016 the Dutch medical charity Zien Zonder Zorgen (ZIZOZ) very kindly donated €14,000 to help support the costs of our forthcoming robotic surgery trial assessing applicability of the robotic surgical system manufactured by the Dutch medical robotics firm PRECEYES for high-precision vitreoretinal surgery and targeted drug delivery.

 

 

 

Hospital Saturday FundFurther donation from The Hospital Saturday Fund

(9 December 2015)

 

 

 

Visit by HSF and FFS (9 December 2015)On 9 December 2015 the Clinical Ophthalmology Research Group was honoured by a visit from Paul Jackson, the Chief Executive of the Hospital Saturday Fund, and Catherine Matson, the Senior Trust Fundraiser at Fight for Sight.

During their visit Mr Jackson presented Professor Robert MacLaren with a of £10,000 as a donation towards the purchase of an ophthalmic operating microscope with an integrated optical coherence tomography (OCT) scanner.

This generous donation follows an earlier donation of £2,000 by The Hospital Saturday Fund in August 2015. Fight for Sight has also pledged its support towards this fundraising campaign.

 

 

 

Hospital Saturday FundDonation from The Hospital Saturday Fund

(11 August 2015)

 

 

 

 

Visit by HSF and NERC (11 August 2015)On 11 August 2015 the Clinical Ophthalmology Research Group was pleased to welcome Paul Jackson and Mike Daw, the respective Chief Executive Officers of the Hospital Saturday Fund and the National Eye Research Centre.

During their visit, a cheque of £2,000 from The Hospital Saturday Fund was presented to Professor Robert MacLaren as a donation towards the purchase of an ophthalmic operating microscope with an integrated optical coherence tomography (OCT) scanner.

The National Eye Research Centre has also pledged its support towards this fundraising campaign.

 

 

 

Choroideremia Research FoundationDonation from the Choroideremia Research Foundation (USA)

(13 February 2015)

 

 

 

 

On 13 February 2015, Dr Christopher Moen, the President of the Choroideremia Research Foundation (USA) very kindly agreed to assist the Clinical Ophthalmology Research Group in its project to raise funds for an ophthalmic operating microscope with an integrated optical coherence tomography (OCT) scanner.

The OCT microscope will provide a head-up display of a cross section of the retina in real time for the surgeon, and will thereby permit the gene therapy vector to be delivered more safely and more accurately in our forthcoming Phase 2 choroideremia gene therapy trial.

The Choroideremia Research Foundation has pledged a donation of $47,000 which is a great start to our fundraising campaign.

 

 

Amar-Franses and Foster-Jenkins Trust

 

Donation from The Amar-Frances & Foster-Jenkins Trust

(29 August 2014)

 

 

 

On 29 August 2014 the Clinical Ophthalmology Research Group was very pleased to welcome Maureen Amar and Richard Jenkins, Trustees of The Amar-Franses & Foster-Jenkins Trust, to Oxford to thank them for their very generous donation of £30,000 (£10,000 per year over three years) for research in the field of macular degeneration. The funds will be used to support the research project to be undertaken by Dr Mark Hassall, a medical graduate from Australia who has obtained a Rhodes Scholarship to study at the University of Oxford.

Dr Hassall will undertake a DPhil research project under the supervision of Professor Robert MacLaren in which he will investigate the application of gene therapy for the treatment of macular degeneration.